Skip to main content

Table 2 Comparisons of grade 3–4 AEs between the three groups

From: Safety of different amphotericin B formulations among AIDS patients with invasive fungal disease: a retrospective observational study

 

AmB

L-AmB

ABCD

p value

(n = 139)

(n = 51)

(n = 15)

AmB vs. L-AmB

AmB vs. ABCD

L-AmB vs. ABCD

Total grade 3–4 AEs, n(%)

50 (36.0)

9 (17.6)

10 (66.7)

0.02

0.02

0.001

 Grade 3, n(%)

32 (23.0)

7 (13.7)

2 (13.3)

0.16

0.59

1.00

 Grade 4, n(%)

18 (12.9)

2 (3.9)

8 (53.3)

0.13

< 0.001

< 0.001

Grade 3–4 hepatotoxicity, n(%)

2 (1.4)

0 (0.0)

0 (0.0)

1.00

1.00

/

 Grade 3, n(%)

2 (1.4)

0 (0.0)

0 (0.0)

1.00

1.00

/

 Grade 4, n(%)

0 (0.0)

0 (0.0)

0 (0.0)

/

/

/

Grade 3–4 nephrotoxicity, n(%)

37 (26.6)

6 (11.8)

4 (26.7)

0.03

1.00

0.31

 Grade 3, n(%)

23 (16.5)

4 (7.8)

2 (13.3)

0.20

1.00

0.89

 Grade 4, n(%)

14 (10.1)

2 (3.9)

2 (13.3)

0.29

1.00

0.47

Grade 3–4 hematological toxicity, n(%)

13 (9.3)

1 (2.0)

10 (66.7)

0.16

< 0.001

< 0.001

 Grade 3, n(%)

9 (6.5)

1 (2.0)

2 (13.3)

0.38

0.65

0.25

 Grade 4, n(%)

4 (2.9)

0 (0.0)

8 (53.3)

0.57

0.001

< 0.001

Grade 3–4 neutropenia, n(%)

6 (4.3)

0 (0.0)

8 (53.3)

0.19

0.008

< 0.001

 Grade 3, n(%)

3 (2.1)

0 (0.0)

3 (20)

0.56

0.007

0.01

 Grade 4, n(%)

3 (2.1)

0 (0.0)

5 (33.3)

0.56

< 0.001

< 0.001

Grade 3–4 hypohemoglobin, n(%)

4 (2.9)

0 (0.0)

0 (0.0)

0.57

1.00

/

 Grade 3, n(%)

4 (2.9)

0 (0.0)

0 (0.0)

0.57

1.00

/

 Grade 4, n(%)

0 (0.0)

0 (0.0)

0 (0.0)

/

/

/

Grade 3–4 thrombocytopenia, n(%)

5 (3.6)

1 (2.0)

6 (40.0)

0.92

< 0.001

< 0.001

 Grade 3, n(%)

4 (2.9)

1 (2.0)

2 (13.3)

1.00

0.20

0.25

 Grade 4, n(%)

1 (0.7)

0 (0.0)

4 (26.7)

1.00

< 0.001

0.002